ERBB2 and breast cancer: To elucidate the molecular mechanisms underlying increased apoptosis in USP22-deficient HER2+-BC cells, we focused on the genes of the “HALLMARK_APOPTOSIS” signature that were commonly upregulated in vitro and in vivo.